U.S. shipments of COVID-19 molecular diagnostic tests reached 1 million per day for the week ending July 24, based on the latest data from AdvaMed’s national testing registry.
The medtech trade group launched the registry July 21 to aid state and federal pandemic responses.
“This incredible milestone is just the latest example of how the medical technology industry is rising to meet the challenges posed by the COVID-19 pandemic,” said AdvaMed president & CEO Scott Whitaker in a news release. “Widespread and widely available testing is key to our ability as a nation to overcome this public health crisis, and our industry is committed to providing the testing supplies and information health care providers need in order to achieve the necessary testing capacity.”
Get the full story on our sister site, Medical Design & Outsourcing.